Access support for products, including cleaning and disinfecting information, video tutorials and more.
Explore a comprehensive portfolio of product and service solutions for managing COVID-19 patients.
Access support for products, including cleaning and disinfecting information, video tutorials and more.
Explore a comprehensive portfolio of product and service solutions for managing COVID-19 patients.
Documents
Documents
Philips is working around the clock to ramp up production of hospital ventilators and other critical care products to help diagnose and treat patients with the novel coronavirus (COVID-19). As initially communicated in March, we are doubling our production of hospital ventilators in May and will achieve a four-fold increase by the third quarter of 2020. Our efforts to increase production have included:
Our most needed products right now include our patient vital-signs monitors and portable ventilators and medical consumables for non-invasive and invasive ventilation to treat a broad range of respiratory conditions. Philips products and solutions to manage COVID-19 include:
For technical support and product servicing, we strongly recommend that only trained service personnel who have knowledge and experience with our ventilators, and who have read and comply with the instructions in the service manual, should service Philips ventilators.
Customers can continue to order parts directly from their Philips account executive or technical support contact. Third party service providers can continue to order parts through distributors.
Philips maintains a Business Continuity Management System, which is aligned to, and certified against, the international standard for Business Continuity ISO 22301:2012. We are constantly reviewing precautionary measures based on WHO and national authority guidelines. Despite the COVID-19 pandemic, Philips has been able to continue its business operations around the world. As expected, we are seeing decreased demand for our consumer product portfolio in the most affected regions, and increased demand for our professional healthcare portfolio. Philips has a balanced manufacturing footprint across the globe, with manufacturing sites in North America, Latin America, Europe, and Asia, including several in China. In line with our business continuity system, we have implemented the relevant safety protocols in all our worldwide sites.
Every patient suffering from chronic respiratory disease has changing therapeutic demands. With DreamStation BiPAP AVAPS non-invasive ventilation solutions, you have the power to treat them that way. Using clinically proven therapy solutions, DreamStation noninvasive ventilators adapt to these changing patient needs, helping to normalise ventilation.
Inspired by you and your patients, the bi-level ventilator BiPAP A40 has been designed to combine ease-of-use and comfort with technological innovations that adapt to your patient’s condition to deliver enhanced therapy. The AVAPS-AE fully automatic ventilation mode, supports long term therapy compliance.
Philips EarlyVue VS30 vital signs monitor unleashes the power of automated Early Warning Scoring (EWS) to help you quickly pinpoint subtle signs of patient deterioration, and confidently deliver proactive care. Early detection, intelligent intervention.
Philips IntelliVue Patient Monitoring Basic Operation
Philips Respironics V60 Use for Invasive Ventilation
Philips IntelliVue Patient Monitoring Understanding Alarms
Clinical care providers discuss topics related to the treatment of COVID-19.
A report from Dr. Adam Seiver, Head of Medical Office for Philips Monitoring Analytics and Therapeutic Care.
Seeing the life-saving community in action around us keeps us hopeful and motivates us to stay focused on our core responsibilities: fulfilling critical customer needs; ensuring the health and safety of employees; and supporting the wellbeing of people around the world.
You are about to visit a Philips global content page
ContinueYou are about to visit the Philips USA website.
I understand